Long QT Syndrome

Jervell, 1957, Congenital deal-mutism, functional heart disease with prolongation of the Q-T interval and sudden death, Am Heart J, 54, 59, 10.1016/0002-8703(57)90079-0 Romano, 1963, Rare cardiac arrythmias of the pediatric age. ii, Clin Pediatr (Bologna), 45, 656 Ward, 1964, A new familial cardiac syndrome in children, J Ir Med Assoc, 54, 103 Moss, 1971, Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome, N Engl J Med, 285, 903, 10.1056/NEJM197110142851607 Moss, 2005, 25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome, Circulation, 111, 1199, 10.1161/01.CIR.0000157069.91834.DA Moss, 2005, Long QT syndrome: from channels to cardiac arrhythmias, J Clin Invest, 115, 2018, 10.1172/JCI25537 Sanguinetti, 1999, Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia, Ann N Y Acad Sci, 868, 406, 10.1111/j.1749-6632.1999.tb11302.x Sanguinetti, 1996, Coassembly of K(V) LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel, Nature, 384, 80, 10.1038/384080a0 Abbott, 1999, MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia, Cell, 97, 175, 10.1016/S0092-8674(00)80728-X Bennett, 1995, Molecular mechanism for an inherited cardiac arrhythmia, Nature, 376, 683, 10.1038/376683a0 Splawski, 2000, Spectrum of mutations in long-QT syndrome genes, Circulation, 102, 1178, 10.1161/01.CIR.102.10.1178 Schott J-J, 2002, Mutation in the ankyrin-B gene causes long QT syndrome and sinus node dysfunction, Circulation, 106, II308 Plaster, 2001, Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome, Cell, 105, 511, 10.1016/S0092-8674(01)00342-7 Splawski, 2004, Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism, Cell, 119, 19, 10.1016/j.cell.2004.09.011 Vatta, 2006, Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome, Circulation, 114, 2104, 10.1161/CIRCULATIONAHA.106.635268 Medeiros-Domingo, 2007, SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome, Circulation, 116, 134, 10.1161/CIRCULATIONAHA.106.659086 Moss, 1995, ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome, Circulation, 92, 2929, 10.1161/01.CIR.92.10.2929 Zhang, 2000, Spectrum of ST–T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes, Circulation, 102, 2849, 10.1161/01.CIR.102.23.2849 Goldenberg, 2006, QT interval: how to measure it and what is “normal.”, J Cardiovasc Electrophysiol, 17, 333, 10.1111/j.1540-8167.2006.00408.x Schwartz, 1993, Diagnostic criteria for the long QT syndrome: an update, Circulation, 88, 782, 10.1161/01.CIR.88.2.782 Lande, 2000, Steady-state versus nonsteady-state QT-RR relationship in 24-hour Holter recordings, Pacing Clin Eletrophysiol, 23, 293, 10.1111/j.1540-8159.2000.tb06752.x Swan, 1999, Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects, J Am Coll Cardiol, 34, 823, 10.1016/S0735-1097(99)00255-7 Shimizu, 2003, Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome, J Am Coll Cardiol, 41, 633, 10.1016/S0735-1097(02)02850-4 Tester, 2006, Effect of clinical phenotype on yield of long QT syndrome genetic testing, J Am Coll Cardiol, 47, 764, 10.1016/j.jacc.2005.09.056 Ackerman, 2005, Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?, Curr Opin Cardiol, 20, 175, 10.1097/01.hco.0000163668.44141.89 Priori, 1999, Low penetrance in the long-QT syndrome clinical impact, Circulation, 99, 529, 10.1161/01.CIR.99.4.529 Napolitano, 2000, Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias, J Cardiovasc Electrophysiol, 11, 691, 10.1111/j.1540-8167.2000.tb00033.x Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, JAMA, 296, 1249, 10.1001/jama.296.10.1249 Sauer, 2007, Long QT syndrome in adults, J Am Coll Cardiol, 49, 329, 10.1016/j.jacc.2006.08.057 Goldenberg, 2008, Time-dependent gender differences in the clinical course of patients with the congenital long-QT syndrome, 28 Locati, 1998, Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry, Circulation, 97, 2237, 10.1161/01.CIR.97.22.2237 Zareba, 2003, Modulating effects of age and gender on the clinical course of long QT syndrome by genotype, J Am Coll Cardiol, 42, 103, 10.1016/S0735-1097(03)00554-0 Goldenberg, 2008, Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome, Circulation, 117, 2184, 10.1161/CIRCULATIONAHA.107.701243 Drici, 1996, Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart, Circulation, 94, 1471, 10.1161/01.CIR.94.6.1471 Boyle, 1987, Hormonal regulation of K+ channel messenger RNA in rat myometrium during oestrus cycle and in pregnancy, Nature, 330, 373, 10.1038/330373a0 Seth, 2007, Long QT syndrome and pregnancy, J Am Coll Cardiol, 49, 1092, 10.1016/j.jacc.2006.09.054 Moss, 1991, The long QT syndrome, Circulation, 84, 1136, 10.1161/01.CIR.84.3.1136 Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 Zareba, 1998, International Long-QT Syndrome Registry Research Group, N Engl J Med, 339, 960, 10.1056/NEJM199810013391404 Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 Moss, 1993, Measurement of the QT interval and the risk associated with QTc interval prolongation: a review, Am J Cardiol, 72, 23B, 10.1016/0002-9149(93)90036-C Goldenberg, 2006, Corrected QT variability in serial ECGs in long QT syndrome: the importance of the maximum QTc for risk stratification, J Am Coll Cardiol, 47, 1811, 10.1016/j.jacc.2005.12.048 Schwartz, 2001, Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias, Circulation, 3, 89, 10.1161/01.CIR.103.1.89 Khositseth, 2004, Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome, Heart Rhythm, 1, 60, 10.1016/j.hrthm.2004.01.006 Moss, 1999, Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome, Am J Cardiol, 84, 876, 10.1016/S0002-9149(99)00458-0 Vincent, 1992, The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome, N Engl J Med, 27, 846, 10.1056/NEJM199209173271204 Moss, 2007, Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene, Circulation, 115, 2481, 10.1161/CIRCULATIONAHA.106.665406 Moss, 2002, Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel, Circulation, 105, 794, 10.1161/hc0702.105124 Crotti, 2007, The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification, Circulation, 116, 2366, 10.1161/CIRCULATIONAHA.107.726950 Brink, 2005, Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population, Circulation, 112, 2602, 10.1161/CIRCULATIONAHA.105.572453 Liu J, Goldenberg I, Moss AJ, et al. Phenotypic variability in caucasian and Japanese patients with matched LQT1 mutations. Ann Noninvasive Electrocardiol 2008. In press. Moss, 2000, Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome, Circulation, 101, 616, 10.1161/01.CIR.101.6.616 Goldenberg, 2008, Long-QT syndrome after age 40, Circulation, 116, 2192, 10.1161/CIRCULATIONAHA.107.729368 Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 Zareba, 2003, Implantable cardioverter defibrillator in high-risk long QT syndrome patients, J Cardiovasc Electrophysiol, 14, 337, 10.1046/j.1540-8167.2003.02545.x Goel, 2004, Implantable cardioverter defibrillator therapy in children with long QT syndrome, Pediatr Cardiol, 4, 370 Zareba W, Moss AJ, Daubert JP, Rosero S, Huang D, Andrews M. Arrhythmic events in LQTS patients with implantable cardioverter defibrillators (abstr). Heart Rhythm 2004; Suppl 1:532. Schwartz, 2006, The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome, Circulation, 113, 783, 10.1161/CIRCULATIONAHA.105.592899 Goldenberg, 2006, Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome, J Cardiovasc Electrophysiol, 17, 1169, 10.1111/j.1540-8167.2006.00587.x Kaufman E, McNitt S, Moss AJ, et al. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm 2008. In press. Goldenberg, 2005, Cost effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias, Ann Noninvasive Cardiol, 4, 67, 10.1111/j.1542-474X.2005.00070.x Sanders, 2005, Cost-effectiveness of implantable cardioverter-defibrillators, N Engl J Med, 353, 1471, 10.1056/NEJMsa051989 Zwanziger, 2006, The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II, J Am Coll Cardiol, 47, 2310, 10.1016/j.jacc.2006.03.032 Schwartz, 2004, Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome, Circulation, 109, 1826, 10.1161/01.CIR.0000125523.14403.1E Dorostkar, 1999, Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing, Circulation, 100, 2431, 10.1161/01.CIR.100.24.2431 Haissaguerre, 2003, Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes, Circulation, 108, 925, 10.1161/01.CIR.0000088781.99943.95 Khan, 2004, Novel therapeutics for treatment of long-QT syndrome and torsade de pointes, Int J Cardiol, 95, 1, 10.1016/j.ijcard.2003.04.018